Product Reports Resources Pricing Login Book a demo

Onalabs

Biotech & Life Sciences · Barcelona, Spain · Founded 2016

Wearable devices for non-invasive biomarker monitoring MoreLess

Onalabs is a medical technology company founded in Barcelona, Spain, in December 2016 by Elisabet del Valle (CEO), Xavier Munoz (CSO), and Jordi Garriga. The founders' backgrounds are in science and patents, which has guided the company's focus on protecting its intellectual property. Del Valle, with a background in biochemistry, was driven by a fascination with life sciences to co-found the company. Onalabs has secured a total of $3.18 million in funding over seven rounds, including grants and seed funding. A notable seed round in October 2023 raised $1.9 million, led by FC Barcelona's Barça Innovation Hub (BIHUB), which became a strategic partner and shareholder.

The company develops non-invasive, wearable medical devices that analyze biomarkers in sweat, effectively turning the skin into a data platform. Its business model includes both direct-to-consumer (B2C) sales and collaborations with distributors (B2B2C). The core technology is based on sensory bioengineering and uses disposable cartridges for sweat collection and analysis, which are connected to a mobile app and cloud platform. Onalabs holds the ISO 13485 certification for medical device quality management and a manufacturing license from the Spanish Agency of Medicines and Medical Devices (AEMPS).

Onalabs has three main products. ONASPORT is a chest strap device for athletes that measures lactate levels, electrolyte loss, dehydration, and heart rate in real-time to optimize training and prevent injuries. It has been tested with sports institutions like CAR Sant Cugat and INEFC-UB and is being further developed with FC Barcelona's athletes. The company launched its first physical retail point for ONASPORT in Andorra in February 2026. The second product, ONAVITAL, is designed for remote monitoring of chronic patients, tracking vital signs such as arterial pressure, oxygen saturation, and skin temperature. A third product, ONADM, is in the laboratory phase and aims to provide non-invasive, continuous glucose monitoring for diabetic patients.

Keywords: non-invasive monitoring, wearable biosensors, sweat analysis, biomarker detection, sports performance, remote health monitoring, chronic disease management, lactate monitoring, digital health, medical devices, sensory bioengineering, FC Barcelona, Barça Innovation Hub, ONASPORT, ONAVITAL, Elisabet del Valle, Xavier Munoz, sports technology, athlete monitoring, personalized medicine, MedTech, health data platform

Talent graph

Onalabs's talent

Book a demo to see the people
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

8 investors on Onalabs's cap table

Sourced from Dealroom's funding and investor records.

Seed 8 investors entered at this stage
European Innovation Council
Capital Cell
Barca Innovation Hub
NPrime Partners Capital
WA4STEAM
Ninteen Twenty-One
SETT
Reig Patrimonia

Global footprint

Where Onalabs has talent and traffic

Workforce by country
2 countries with
team presence
🇪🇸 Spain96.3%
🏳️ Andorra3.7%
2 countries shown

Market sentiment

What the market is saying about Onalabs

An AI-synthesized read of the highest-engagement posts about Onalabs on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Onalabs on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.